U.S. Optical Retail Market Estimated at $76.5 Billion in The Vision Council’s First Comprehensive Market inSights Report

By Staff
Friday, January 6, 2023 12:27 AM ALEXANDRIA, Va.—Today, The Vision Council will release its first set of comprehensive industry estimates since last year’s inSights Research Program launch. The inaugural Market inSights 2022 Report estimates that the overall size of the U.S. optical retail industry was $76.5 billion as compared to $76.09 billion for 2021, according to an announcement from The Vision Council. Both the 2021 and 2022 figures use the new methodology associated with The Vision Council's Market inSights Report.

IOT Names Winner of ‘Optical’s Next Top Speaker’ Contest

By Staff
Tuesday, November 29, 2022 12:21 AM TORRANCE, Calif.—Lens technology company IOT announced that Minerva Maldonado, a Connecticut-based optician, is the winner of its 2022 “Optical’s Next Top Speaker” contest. The contest, sponsored by IOT, encouraged opticians to develop their speaking skills and share knowledge with industry peers.

Transitions Optical to Host ‘Day of Education’ in November

By Staff
Wednesday, October 5, 2022 12:21 AM PINELLAS PARK, Fla.—Transitions Optical will host “A Day of Education” on Wednesday, November 2. The online event will include various sessions between 10:00 a.m. – 4:00 p.m. EST.

Opening Your Eyes: The Vision Council Scholarship Fund Expands to Seven Additional Institutions Within the National Federation of Opticianry Schools

By Staff
Monday, July 25, 2022 12:24 AM ALEXANDRIA Va.—The Vision Council today announces that the Opening Your Eyes: The Vision Council Scholarship Fund is expanding to seven additional institutions within the National Federation of Opticianry Schools (NFOS), including: Daytona State College (Fla.), Erie Community College (N.Y.), Miami Dade College (Fla.), Middlesex Community College (Conn.), Raritan Valley Community College (N.J.), Reynolds Community College (Va.), and Wiregrass Georgia Technical College (Ga.). The additional schools mark an expansion from the scholarship’s launch schools—Georgia Piedmont Technical College, New York City Technical College, and Middlesex Community College—and the two  partners that were added in May 2022, Durham Technical Community College (Durham, N.C.) and Hillsborough Community College (Fla.).

Specsavers Intends to Hire 400 Opticians in Canada by 2024, Names Claudia Rojas as Head of Opticianry to Lead the Effort

By Staff
Friday, July 22, 2022 12:18 AM VANCOUVER—Specsavers said this week that it has set out to build the largest network of opticians in Canada, which the U.K.-founded company said is part of its plan “to ensure clinical excellence,” according to the company’s announcement.

New Jobson Optical Research Study Explores ‘Digital Solutions for ECPs’

By Staff
Thursday, July 14, 2022 12:15 AM NEW YORK—Jobson Optical Research is releasing “Digital Solutions for ECPs,” a new study that reveals how eyecare professionals are using digital solutions within their practice and dispensary in 2022.

Registration Now Open for Vision Expo West 2022, Set for September 14-17 in Las Vegas

By Staff
Thursday, June 23, 2022 12:21 AM ALEXANDRIA, Va.—Registration opens today for Vision Expo West, taking place Sept. 14-17, 2022 in Las Vegas at the Venetian Expo & Convention Center.

Presbyopia: The Art and Science of Matching Patients With Solutions

By Andrew Karp
Wednesday, June 22, 2022 1:30 AM Along with receding hairlines, crow’s feet and sagging skin, presbyopia is one of the least welcome physical changes we experience as we age. The gradual loss of our eyes’ ability to focus on nearby objects, a result of the stiffening of the crystalline lens, is an inevitable condition for most of us who are middle aged and older. In fact, you could even add presbyopia to the familiar litany of death and taxes. And it only gets worse with time.

The Power of Presbyopia Drops

By Joseph P. Shovlin, OD
Wednesday, June 22, 2022 1:29 AM The first drop for presbyopia, Vuity (pilocarpine hydrochloride, Allergan), has recently gained FDA approval and has received much attention. It provides a pharmaceutical option beyond spectacles, contact lenses and surgery. The new drug is now readily available and easy to administer with fast onset and sufficient duration for most (about six hours). Even though this product has only been used for just a few months, reports have been positive.